Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Azelastine Hydrochloride Nasal Solution Manufacturer

Active

Federal

Response Deadline10/05/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the manufacture and supply of Azelastine Hydrochloride Nasal Solution 0.1% for prime contractors supporting the Defense Logistics Agency. The selected provider is responsible for the chemical synthesis, formulation to deliver 137 mcg per spray, and primary packaging of the finished drug product. Operations must be conducted in clean room facilities using pharmaceutical-grade mixing equipment in strict compliance with cGMP standards. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA, with the place of performance located at Fort Drum. Interested parties must respond by October 5, 2026, for this requirement categorized under NAICS code 325411.

General Info

Manufacture and supply Azelastine Hydrochloride Nasal Solution for DoD at Fort Drum.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

FORT DRUM, NY, 13602-5000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-5280.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

AZELASTINE HYDROCHLORI

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 28

subcontract

Response DeadlineOct 5

Submission deadline

Response Deadline

10/05/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies the active pharmaceutical ingredient and finished drug product for prime contractors on Defense Logistics Agency (DLA) pharmaceutical supply contracts. Performs chemical synthesis, formulation of 0.1% nasal solution to deliver 137 mcg per spray, and primary packaging. Requires pharmaceutical-grade mixing equipment and clean room facilities. Must comply with cGMP standards. Delivers finished Azelastine Hydrochloride Nasal Solution 0.1% units.

Similar Contracts

Same NAICS industry code

AZELASTINE HYDROCHLORI

Solicitation # SPE2DP-26-T-5280

Solicitation SPE2DP-26-T-5280 is issued by the DLA Troop Support Medical Supply Chain for the procurement of Azelastine Hydrochloride Nasal Solution 0.1% nasal spray, with each spray delivering 137 micrograms. The requirement consists of 6 bottles to be delivered to the 0548 CS BN CO A Composite at Fort Drum, New York. The original required delivery date is September 29, 2026, with a delivery window of 20 days after the order. The product must be stored upright between 20 C and 25 C and protected from freezing in accordance with USP controlled room temperature standards. The contract mandates that all materials be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers to prevent damage, and must comply with DLA Packaging Requirements for Procurement RP001. Inspection and acceptance will occur at the destination. The procurement is subject to the Buy American Act and Balance of Payments Program for quotes exceeding the micro-purchase threshold. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and adherence to various FAR and DFARS clauses regarding hazardous material identification, cybersecurity, and the combating of trafficking in persons.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

ETHYL CHLORIDE SPRAY

Solicitation # SPE2DP-26-T-5276

Solicitation SPE2DP-26-T-5276 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of four bottles of Ethyl Chloride Spray, identified by NSN 6505-01-652-4916. The product is a 100 percent active ingredient aerosol spray for topical application, with each bottle containing 3.5 fluid ounces (103.5 ml) and providing approximately 50 five-second applications. The item is regulated by the FDA and is classified as a flammable gas, requiring strict adherence to hazardous materials regulations, including the provision of a current Material Safety Data Sheet with each shipment and compliance with 49 CFR and ICAO technical instructions. The contract specifies a total shelf life of 36 months, with a minimum of 31 months remaining upon receipt by the government. Delivery is set for FOB Destination to a facility in Germany, with an original required delivery date of September 29, 2026. Packaging must be commercial and comply with Medical Marking Standard No. 1A, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. Offerors must submit quotes via the DIBBS portal by October 5, 2026, and comply with various federal regulations, including the Buy American Act and DFARS requirements regarding covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

CALCIUM GLUCONATE INJE

Solicitation # SPE2DP-26-T-5262

Solicitation SPE2DP-26-T-5262 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Calcium Gluconate Injection (NSN 6505017149103). The requirement is for one single-dose vial of preservative-free Calcium Gluconate Inj USP (100mg/ml, 10ml), indicated for the treatment of acute symptomatic hypocalcemia in pediatric and adult patients for H9D use only. The product must be stored at controlled room temperature between 20C to 25C and must not be frozen. The item has a non-extendable shelf life of 24 months. Delivery is set for September 29, 2026, with a lead time of 5 days after order, shipped FOB Destination to the 405th AFSB in Vilseck, Germany. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and RP001. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Invoicing and payment must be processed through the Wide Area WorkFlow system. The solicitation falls under NAICS 325411 and incorporates various FAR and DFARS clauses, including those regarding the Buy American Act and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CALCIUM GLUCONATE INJE

Solicitation # SPE2DP-26-T-5266

This fixed-price solicitation, issued by the DLA Troop Support Medical Supply Chain Pharma FSA, is for the acquisition of Calcium Gluconate Injection, USP 100mg/ml (10%) intravenous solution. The requirement specifies preservative-free solution provided in 20 x 100ml vials. The product must be stored at 20 to 25 degrees Celsius and must not be frozen. It requires a total shelf life of 36 months, with a mandate that no more than 31 months have elapsed from the date of manufacture to the date of delivery to the government. Delivery is set for FOB Destination at Fort Campbell, Kentucky, with an original required delivery date of September 17, 2026. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001 standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. Payment and invoicing shall be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DOXYCYCLINE HYCLATE TA

Solicitation # SPE2DP-26-T-5265

Solicitation SPE2DP-26-T-5265 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Doxycycline Hyclate Tablets, NSN 6505-01-687-1016. The requirement consists of 20 bottles, each containing 28 tablets of 100mg antibacterial drug synthetically derived from oxytetracycline. The items must be delivered FOB Destination to Fort Bragg, North Carolina, within 20 days of the award. The product must be dispensed in tight, light-resistant containers with child-resistant closures and stored at a controlled room temperature between 20C and 25C. The contract specifies a total shelf life of 60 months, with a requirement that no more than 9 months have elapsed from the date of manufacture to the date of delivery to the government. Labeling must adhere to Medical Marking Standard No. 1 and include the NSN, manufacturer, CAGE code, contract and lot numbers, and the date of manufacture prefixed by MFD. Packaging must comply with DLA Master List requirements, specifically RP001, and ASTM D3951 for non-hazardous materials. All quotes must be submitted via the DIBBS system by October 5, 2026, and the award may be subject to automated processing or HUBZone price evaluation preferences.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICAL

Solicitation # SPE2DP-26-T-5224

Solicitation SPE2DP-26-T-5224 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of two cases of topical analgesic gel. The product consists of Menthol USP 5% gel provided in 4 oz tubes, with 144 tubes per case. This item is classified as a Type I Code M product with a non-extendable shelf life of 24 months and must be stored at 20-25 degrees Celsius. Due to its flammable nature, the material must be kept away from excessive heat or open flames. Delivery is required within 20 days after order, with shipping, inspection, and acceptance all occurring at the destination. The contract mandates strict adherence to hazardous materials regulations, requiring the submission of Safety Data Sheets and labels compliant with OSHA and 29 CFR 1910.1200. Packaging must follow DLA requirements and 49 CFR, ICAO, or IMDG standards, with a signed certification of compliance included on the DD Form 250. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and Berry Amendment. The solicitation also incorporates standard FAR and DFARS clauses regarding trafficking in persons, sustainable products, and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORHEXIDINE GLUCONAT

Solicitation # SPE2DP-26-T-5244

Solicitation SPE2DP-26-T-5244 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Chlorhexidine Gluconate Cleansing Solution. The requirement specifically calls for 50 cases of surgical scrub chlorhexidine 16oz dispenser refill bottles (1% / 61%), with each case containing 8 bottles. This procurement is designated as a Total Small Business Set-Aside. The items must be delivered FOB Destination to Rose Barracks South Camp in Vilseck, Germany, with a required delivery date of September 25, 2026, and a delivery window of five days. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers per MIL-STD-2073-1E to prevent damage. Because the material is flammable and hazardous, suppliers must provide Safety Data Sheets and hazard warning labels in accordance with 29 CFR 1910.1200 and Federal Standard No. 313-E prior to award. Additionally, the product must have a total shelf life of 24 months, with a minimum of 321 months of remaining shelf life upon receipt by the first government activity. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5229

Solicitation SPE2DP-26-T-5229 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The required product contains 15mg of Benzocaine and 2.6mg of Menthol, provided in packages of 16. The government is seeking a quantity of 10 units with an original required delivery date of September 25, 2026. Delivery is set as FOB Destination to the USALRCTR Bavaria in Vilseck, Germany, with an inspection and acceptance point also at the destination. The contract mandates strict adherence to medical packaging and marking standards, specifically requiring compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Items must be stored between 20-25 C and protected from humidity, with a non-extendable shelf life of 36 months. Packaging must be commercial and sealed to prevent damage, with palletization following DLA requirement RP001. Administrative requirements include the use of the Wide Area Workflow system for invoicing and payment, and compliance with the Buy American and Balance of Payments Program for quotes exceeding the micro-purchase threshold.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Norgestimate and Ethinyl Estradiol TabletsThis subcontract involves the supply of pharmaceutical-grade Norgestimate and Ethinyl Estradiol tablets to support prime contractors working on Department of Defense projects for the Medical Supply Chain Pharm FSA. The requirement specifies the delivery of 168 tablets, covering six cycles, and mandates strict adherence to FDA regulations for pharmaceutical manufacturing and distribution. The contract is categorized under NAICS code 325411 and is designated for performance at Fort Drum, New York. Interested parties must respond by September 29, 2026, to meet the procurement timeline established by the agency.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 14 hours

NORGESTIMATE AND ETHIN

Solicitation # SPE2DP-26-T-5213

Solicitation SPE2DP-26-T-5213 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of FDA-regulated norgestimate and ethinyl estradiol tablets. The requirement consists of multiple CLINs, each for one package containing 6 cycles and 168 tablets, identified by NSN 6505-01-666-3685. Delivery is required within 10 days after receipt of order, with shipments destined for various locations including Fort Stewart, Georgia; Fort Drum, New York; Vicenza, Italy; Baumholder, Germany; and Fort Stewart, Georgia. The items must be stored at 25 degrees Celsius, protected from light, and have a non-extendable shelf life of 36 months. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129, Medical Marking Standard No. 1, and RP001. Non-hazardous materials must be packaged per ASTM D3951, while hazardous materials require compliance with TQ requirement IP025 and the Hazard Communication Standard. Inspection and acceptance will occur at the destination. Quotes must be submitted via the DIBBS system, and the award process may utilize automated award and HUBZone price evaluation preferences. Compliance with the Buy American Act, Berry Amendment, and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 14 hours

APRACLONIDINE HYDROCHL

Solicitation # SPE2DP-26-T-5202

Solicitation SPE2DP-26-T-5202 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Apraclonidine Hydrochloride 1% Ophthalmic Solution. The requirement consists of one package containing 12 pouches, with each pouch holding two 0.1ML units in a dropperette. The product must be stored between 2 C and 25 C (36 F to 77 F) and has a non-extendable shelf life of 18 months. Delivery is specified as FOB Destination to the Kelly CSDC AFMEDCOM A410W facility in San Antonio, Texas, with a required delivery date of September 24, 2026, and a delivery window of 5 days after order. The contract mandates strict adherence to medical and military standards, including Medical Marking Standard No. 1, MIL-STD-129 for general marking, and MIL-STD-2073-1E for packaging. Palletization must comply with DLA packaging requirement RP001, and any hazardous materials must be labeled according to the Hazard Communication Standard. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The solicitation is governed by NAICS code 325411 and incorporates various FAR and DFARS clauses regarding small business representations, cybersecurity safeguarding, and domestic material restrictions such as the Buy American Act and the Berry Amendment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 14 hours

POTASSIUM IODIDE TABLE

Solicitation # SPE2DP-26-T-5204

This Request for Quotations, solicitation number SPE2DP-26-T-5204, is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Potassium Iodide Tablets. The requirement specifies 130mg (KI) tablets provided in foil-sealed packages of 14 unit doses, with a total quantity of 24 packages. These items are classified as Type I (Code W) with a non-extendable shelf life of 120 months and must be stored at temperatures between 20-25°C (68-77°F) in dry conditions with the foil intact. The delivery is required within 20 days, FOB Destination, to Tyndall AFB, Florida. The contract incorporates rigorous technical, quality, and packaging standards, including compliance with MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129. Offerors must adhere to strict packaging requirements to ensure the protection of contents and safe delivery via commercial carriers. Regulatory compliance is mandatory, as the drug is regulated by the FDA, and the solicitation includes various federal and defense acquisition regulations regarding equal opportunity, combating human trafficking, hazardous material safety, and domestic material restrictions such as the Buy American Act and the Berry Amendment. All payment requests and receiving reports must be processed electronically through the Wide Area Workflow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 14 hours

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Medical-Grade Packaging and Delivery ServicesThis subcontract for Medical-Grade Packaging and Delivery Services involves providing specialized packaging and shipping support for prime contractors on DLA supply contracts. The service provider is responsible for packaging items according to MIL-STD-2073-1E and ASTM D3951, while ensuring all markings adhere to Medical Marking Standard No. 1. Additionally, the contractor must handle hazardous materials in compliance with TQ Requirement IP025 and FED-STD-313, utilizing sealed unit containers and 29 CFR 1910.1200 labeling. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA and falls under NAICS code 561910. All shipments must be delivered properly packaged on an FOB Destination basis. The solicitation was posted on September 28, 2026, with a response deadline of October 5, 2026.

Packaging and Labeling Services

POSTED

about 10 hours ago

DEADLINE

Supply of NSN 6505-01-624-7068This subcontract involves the manufacture or sourcing of two units of medical component NSN 6505-01-624-7068 for prime contractors under DLA supply contracts. The provider must ensure the material meets all technical specifications and adheres to strict regulatory requirements, specifically DFARS 252.225-7007 regarding prohibited sources and DFARS 252.223-7008 concerning hexavalent chromium. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA with a NAICS code of 339112. It was posted on September 28, 2026, and requires a response by October 5, 2026.

Surgical and Medical Instrument Manufacturing

POSTED

about 10 hours ago

DEADLINE

Supply of Permethrin Cream Rinse (NSN 6505012564972)This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of six units of Permethrin Cream Rinse for primes delivering DLA Troop Support medical supply contracts. The product must contain a 1% w/v Permethrin active ingredient, packaged in 2 fl oz plastic squeeze bottles and include a comb. All supplies must adhere to NSN 6505012564972 specifications and maintain a minimum remaining shelf life of 21 months upon receipt. The contract requires full compliance with FAR 52.223-3 and FAR 52.223-23 regulations under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

Supply of Ringer's Injection, LAC (NSN 6505-01-462-3022)This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Ringer's Injection, LAC, identified by NSN 6505-01-462-3022. The contractor must ensure all products meet specific technical specifications, are maintained at a controlled room temperature of 25 degrees Celsius, and are marked according to Medical Marking Standard No. 1. Packaging must adhere to MIL-STD-2073-1E, and all delivered items must have a minimum shelf life of 15 months. The contract is categorized under NAICS code 423450 and requires delivery of one package FOB Destination to Fort Drum, New York. The response deadline for this opportunity is October 5, 2026.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 10 hours ago

DEADLINE

Supply of Benzoin Tincture, Compound (USP)This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of a specialized over-the-counter topical solution for primes delivering DLA Troop Support medical supply contracts. The requirement is for four 16-ounce pharmaceutical-grade bottles of Benzoin Tincture, Compound, formulated to meet USP standards with 1000 mg of benzoin resin per 1 ml and 77 percent alcohol. The opportunity is categorized under NAICS code 325412 and was posted on September 28, 2026, with a response deadline of October 5, 2026. This procurement ensures the delivery of standardized medical supplies necessary for military health operations.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

Temperature-Controlled Medical FreightThis subcontract for Temperature-Controlled Medical Freight involves the transport and delivery of pharmaceutical products for primes supporting Department of Defense supply contracts. The contractor is required to utilize climate-controlled vehicles to maintain Controlled Room Temperature and adhere to strict pharmaceutical shipping standards to ensure all medical supplies remain stable during transit. The scope of work focuses on meeting DLA delivery schedules for FOB Destination delivery under NAICS code 484220. Managed by the Medical Supply Chain Pharm FSA, the opportunity was posted on September 28, 2026, with a response deadline of October 5, 2026.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 10 hours ago

DEADLINE

Cyclosporine Ophthalmic Ointment ManufacturerThis subcontract with the Department of Defense Medical Supply Chain Pharmacy FSA involves the manufacture and supply of Cyclosporine Ophthalmic Ointment for primes delivering DLA supply contracts. The contractor is responsible for producing an ointment containing 0.2% Cyclosporine per gram, filling and sealing 3.5 gram sterile tubes, and packaging these units in sets of six tubes per package. The manufacturer must ensure all finished pharmaceutical packages comply with Medical Marking Standard No. 1, RP001 DLA Packaging Requirements, MIL-STD-2073-1E, and Special Packaging Instructions MPWN00001. This opportunity falls under NAICS code 325412 and has a response deadline of October 5, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

Medical Grade Packaging and Marking ServicesThis subcontract for Medical Grade Packaging and Marking Services involves providing specialized packaging and marking for pharmaceutical products on behalf of prime contractors for Defense Logistics Agency supply contracts. The service provider is responsible for packaging units in sealed unit containers and commercial exterior shipping containers in accordance with MIL-STD-2073-1E and applying markings that adhere to Medical Marking Standard No. 1 to ensure all units are ready for shipment. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA and is categorized under NAICS code 561910. Performance of these services will take place in San Antonio, Texas. The response deadline for this opportunity is October 5, 2026.

Packaging and Labeling Services

POSTED

about 10 hours ago

DEADLINE

Tolnaftate Powder SupplyThis subcontract involves the supply of pharmaceutical-grade Tolnaftate Powder to prime contractors supporting the Defense Logistics Agency within the Department of Defense. The selected provider is responsible for manufacturing or sourcing the powder in strict accordance with the DLA Master List of Technical and Quality Requirements, while ensuring full compliance with the Buy American and Balance of Payments Program. The contract requires the implementation of quality control systems that meet all specified DLA standards to ensure the delivery of high-quality physical supplies. Performance for this requirement is centered in San Antonio, Texas, under NAICS code 325412, with a response deadline set for October 5, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

Supply of Iopamidol Injection (Contrast Agent)This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Iopamidol Injection contrast agent, identified by NSN 6505-01-657-0664. The requirement consists of 100 total single-dose bottles, delivered as 10 packages containing ten 100ML bottles each. All supplies must be delivered FOB Destination to Travis AFB and must strictly adhere to Medical Marking Standard No. 1 and ASTM D3951 packaging materials. The contractor must ensure full compliance with the Buy American Act and all applicable pharmaceutical quality standards for injectable contrast agents. This opportunity falls under NAICS code 424210, with a response deadline of October 5, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 10 hours ago

DEADLINE

Temperature-Controlled Pharmaceutical DistributionThis subcontract for Temperature-Controlled Pharmaceutical Distribution involves the storage and transport of nasal solutions for prime contractors supporting Department of Defense supply contracts. The service is managed by the Medical Supply Chain Pharm FSA and will be performed at Fort Drum. The primary objective is to ensure the delivery of viable products through the use of cold-chain logistics equipment and temperature-monitored containers. The provider must maintain a climate-controlled environment with temperatures strictly between 20°C to 25°C to meet USP Controlled Room Temperature and DLA RP001 packaging standards. This operation falls under NAICS code 484220, with a response deadline set for October 5, 2026.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 10 hours ago

DEADLINE

Supply of Ethyl Chloride Spray (NSN 6505-01-652-4916)This subcontract involves the supply of pharmaceutical-grade Ethyl Chloride Spray (NSN 6505-01-652-4916) for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The requirement is for four bottles of RX-only topical spray, each containing 3.5 fluid ounces of 100 percent active ingredient aerosol with a medium jetstream delivery system. Compliance with MIL-STD-2073-1E, MIL-STD-129, and IP025 is mandatory for the packaging and marking of hazardous materials. Due to the nature of the flammable gas, the provider must hold a valid HAZMAT certification for shipping. The solicitation was posted on September 28, 2026, with a response deadline of October 5, 2026, falling under NAICS code 423460.

Ophthalmic Goods Merchant Wholesalers

POSTED

about 10 hours ago

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS